Lung eicosanoids in perinatal rats with congenital diaphragmatic hernia

4Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abnormal levels of pulmonary eicosanoids have been reported in infants with persistent pulmonary hypertension (PPH) and congenital diaphragmatic hernia (CDH). We hypothesized that a dysbalance of vasoconstrictive and vasodilatory eicosanoids is involved in PPH in CDH patients. The levels of several eicosanoids in lung homogenates and in bronchoalveolar lavage fluid of controls and rats with CDH were measured after caesarean section or spontaneous birth. In controls the concentration of the stable metabolite of prostacyclin (6-keto-PGF(1α)), thromboxane A2 (TxB2), prostaglandin E2 (PGE2), and leukotriene B4 (LTB4) decreased after spontaneous birth. CDH pups showed respiratory insufficiency directly after birth. Their lungs had higher levels of 6-keto-PGF(1α), reflecting the pulmonary vasodilator prostacyclin (PGI2), than those of controls. We conclude that in CDH abnormal lung eicosanoid levels are present perinatally. The elevated levels of 6-keto-PGF(1α) in CDH may reflect a compensation mechanism for increased vascular resistance.

Cite

CITATION STYLE

APA

IJsselstijn, H., Zijlstra, F. J., Van Dijk, J. P. M., De Jongste, J. C., & Tibboel, D. (1997). Lung eicosanoids in perinatal rats with congenital diaphragmatic hernia. Mediators of Inflammation, 6(1), 39–45. https://doi.org/10.1080/09629359791910

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free